Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 24 INDUSTRY 18 OTHER_GOV 1 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 41 Cisplatin 40 Paclitaxel 35 Radiotherapy 32 Docetaxel 19 Pemetrexed 18 Gemcitabine 17 Etoposide 17 Bevacizumab 11 Radiosurgery 10 Magnetic Resonance Spectroscopy 9 Ramucirumab 8 durvalumab 7 Taxes 7 Cetuximab 7 pembrolizumab 6 Specimen Handling 6 Erlotinib Hydrochloride 6 Irinotecan 5 Gene Expression Profiling 5 Filgrastim 5 cediranib 4 Vinorelbine 4 Polymerase Chain Reaction 4 Neoadjuvant Therapy 4 Fluorodeoxyglucose F18 4 Chemotherapy, Adjuvant 4 Amplified Fragment Length Polymorphism Analysis 4 tremelimumab 3 osimertinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × lorlatinib × Thoracic × Clear all

NCT04127110 2024-11-05

ALKALINE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡